Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke [Phase 4]

View source ↗

Summary

Phase 4 study evaluating piracetam for aphasia after acute ischemic stroke (middle cerebral artery territory) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Piracetam (piracetam)

Snippet

Sponsor: UCB S.A. - Pharma Sector | Conditions: Acute Ischaemic Middle Cerebral Artery Stroke | Phase 4 | Status: TERMINATED